Data / Drug companies / Tretinoin
Tretinoin: 28 companies and 85 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Tretinoin is listed in the FDA National Drug Code Directory by 28 companies, with 85 products in commercial distribution. 56 of the products (65.9%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are cream; gel; capsule, and the newest product started marketing on October 1, 2026.
The request: Get every company that lists tretinoin in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 28
- Products
- 85
- Generic (ANDA) products
- 56 (65.9%)
- Application numbers
- 35
- Routes
- Topical, Oral
- Brand names
- Retin-A, Retin-A Micro, Renova, Atralin, Altreno
- openFDA record search
- api.fda.gov
Companies that list tretinoin
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Bausch Health US LLC | 11 | gel; cream | New drug applications (NDA) | August 24, 2018 |
| Encube Ethicals, Inc. | 7 | gel; cream | Generic drugs (ANDA) | April 16, 2026 |
| A-S Medication Solutions | 6 | cream | Generic drugs (ANDA) | January 5, 2023 |
| Mylan Pharmaceuticals Inc. | 6 | cream; gel | Authorized generics (NDA) | August 12, 2019 |
| NuCare Pharmaceuticals,Inc. | 6 | cream | Generic drugs (ANDA) | January 5, 2023 |
| Padagis US LLC | 5 | cream; gel | Generic drugs (ANDA) | June 15, 2017 |
| Bryant Ranch Prepack | 4 | cream; gel | Generic drugs (ANDA) | August 24, 2023 |
| Obagi Cosmeceuticals LLC | 4 | cream; gel | New drug applications (NDA) | June 19, 2014 |
| Oceanside Pharmaceuticals | 4 | gel | Authorized generics (NDA) | December 1, 2023 |
| Alembic Pharmaceuticals Inc. | 3 | cream | Generic drugs (ANDA) | June 11, 2026 |
| Alembic Pharmaceuticals Limited | 3 | cream | Generic drugs (ANDA) | June 11, 2026 |
| NorthStar Rx LLC | 3 | cream | Generic drugs (ANDA) | January 5, 2023 |
| Sun Pharmaceutical Industries, Inc. | 3 | cream | Generic drugs (ANDA) | January 5, 2023 |
| Aurobindo Pharma Limited | 2 | gel | Generic drugs (ANDA) | February 27, 2025 |
| Bryant Ranch Prepack | 2 | gel | Authorized generics (NDA) | August 12, 2019 |
| Preferred Pharmaceuticals Inc. | 2 | cream | Generic drugs (ANDA) | January 28, 2026 |
| Viona Pharmaceuticals Inc | 2 | cream | Generic drugs (ANDA) | October 1, 2026 |
| Zydus Lifesciences Limited | 2 | cream | Generic drugs (ANDA) | October 1, 2026 |
| Actavis Pharma, Inc. | 1 | cream | Authorized generics (NDA) | April 20, 1998 |
| American Health Packaging | 1 | capsule | Generic drugs (ANDA) | July 18, 2013 |
| Amneal Pharmaceuticals NY LLC | 1 | gel | Generic drugs (ANDA) | May 15, 2026 |
| Bausch Health US, LLC | 1 | gel | New drug applications (NDA) | July 26, 2007 |
| Glenmark Pharmaceuticals Inc., USA | 1 | capsule | Generic drugs (ANDA) | December 23, 2016 |
| Major Pharmaceuticals | 1 | capsule | Generic drugs (ANDA) | October 24, 2012 |
| Mayne Pharma | 1 | gel | Generic drugs (ANDA) | October 25, 2024 |
| Par Health USA, LLC | 1 | capsule | Generic drugs (ANDA) | October 24, 2012 |
| Redpharm Drug | 1 | cream | Generic drugs (ANDA) | January 5, 2023 |
| Remedyrepack Inc. | 1 | cream | Generic drugs (ANDA) | October 11, 2021 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Cream | 51 | 60% |
| Gel | 28 | 32.9% |
| Capsule | 5 | 5.9% |
| Lotion | 1 | 1.2% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 56 | 65.9% |
| New drug applications (NDA) | 15 | 17.6% |
| Authorized generics (NDA) | 14 | 16.5% |
Pharmacologic classes
| Class | Products |
|---|---|
| Retinoid | 85 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.